Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients
Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patient With Exacerbation of Pulmonary Infection
Sponsor: Sunnybrook Health Sciences Centre
Terminated
Inadequate enrolment and lack of resources
Other terminated trials from Sunnybrook Health Sciences Centre
Other Cystic Fibrosis Pulmonary Exacerbation trials with similar outcome
A NA clinical study on Cystic Fibrosis Pulmonary Exacerbation, this trial is terminated or withdrawn. The trial is conducted by Sunnybrook Health Sciences Centre and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Oct 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sunnybrook Health Sciences Centre
- Unity Health Toronto
- University of Toronto
For direct contact, visit the study record on ClinicalTrials.gov .